Names
Aucatzyl® Obecabtagene autoleucelIndications and usage
Obecabtagene autoleucel is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Side effects needing medical attention
The most common (non-laboratory) adverse reactions are: cytokine release syndrome (CRS), infections - pathogen unspecified, musculoskeletal pain, viral infections, fever, nausea, bacterial infectious disorders, diarrhea, febrile neutropenia, ICANS, hypotension, pain, fatigue, headache, encephalopathy, and hemorrhage.